Clinical Trial Update: Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of mirabegron and oxybutynin in patients with spinal cord injury-related neurogenic bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Spinal Cord Injury

Drugs mentioned

• Mirabegron (mirabegron)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Kessler Foundation | Conditions: Spinal Cord Injuries, Urinary Bladder, Neurogenic | Phase 2 | Status: UNKNOWN